围绕膝关节的核心肌群强化训练与口服非甾体抗炎药治疗早期膝骨关节炎疗效比较:随机对照试验方案
本研究为12周单盲非劣效性随机对照试验,拟纳入100例早期膝骨关节炎患者,随机分为围绕膝关节的核心肌群强化训练组与口服非甾体抗炎药组。主要结局为WOMAC指数,次要结局包括VAS、SF-36、ROM和等长肌力,于分配前及分配后2、4、8、12周评估。
要点
- 国际骨关节炎研究学会推荐非药物疗法作为主要干预策略,物理治疗为首要方法。
- 围绕膝关节的核心肌群强化训练可能减轻疼痛、改善活动能力及生活质量,但需更大样本高质量研究验证。
- 本试验为12周单盲非劣效性随机对照试验,计划纳入100例早期膝骨关节炎患者。
核心结论
- 本研究旨在探讨围绕膝关节的核心肌群强化训练治疗早期膝骨关节炎的具体有效性。
- 研究结果将为早期膝骨关节炎的早期干预提供治疗依据,并为患者进行自主锻炼提供科学基础。
研究设计与样本
- 12周单盲非劣效性随机对照试验,拟招募100例早期膝骨关节炎患者,随机分为围绕膝关节的核心肌群强化训练组和口服非甾体抗炎药组。
- 主要结局为西安大略和麦克马斯特大学骨关节炎指数(WOMAC),次要结局包括视觉模拟评分(VAS)、36项简明健康调查量表(SF-36)、关节活动度(ROM)和等长肌力。
- 结局评估在分配前及分配后2、4、8、12周进行,数据收集者和统计师设盲,并要求参与者不向评估者透露分组。
- 试验在中国临床试验注册中心注册(ChiCTR2400089758),于2024年9月14日前瞻性注册。
临床怎么用
- 国际骨关节炎研究学会推荐非药物疗法作为主要干预策略,物理治疗被确定为主要方法。
- 作者认为围绕膝关节的核心肌群强化训练可能有效减轻疼痛、增强活动能力、改善生活质量,并避免当前康复训练项目治疗时间长、程序复杂和需要医疗监督的限制,但尚需进一步高质量研究验证。
局限性
- 初步临床观察提示围绕膝关节的核心肌群强化训练可能有效,但尚需更大样本量的高质量研究来最终验证其疗效。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Knee osteoarthritis (KOA) is a prevalent condition characterized by a high incidence and disability rate, making early intervention particularly critical. It is essential to focus on addressing the underlying disease rather than solely alleviating symptoms through pharmacological treatments. The Osteoarthritis Research Society International recommends non-pharmacological therapies as the primary intervention strategy, with physical therapy identified as the principal method. Current rehabilitation training programs often present challenges, including prolonged treatment durations, complex procedures, and the necessity for medical supervision. Preliminary clinical observations suggest that core muscle strengthening training around the knee (CMSTK) may effectively reduce pain, enhance mobility, improve quality of life, and avoid the aforementioned limitations. Nevertheless, further high-quality research with larger sample sizes is required to validate its efficacy conclusively. This study aims to investigate the specific effectiveness of CMSTK for the treatment of EKOA. METHODS: This study is a 12-week single-blind non-inferiority randomized controlled trial. One hundred early-stage knee osteoarthritis (EKOA) patients will be recruited and randomly divided into CMSTK group and oral nonsteroidal anti-inflammatory drugs group. The primary outcome is the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) and secondary outcomes involves VAS, SF-36, ROM, and isometric strength. They will be conducted before allocation and at 2, 4, 8, and 12 weeks after allocation. Comprehensive efficacy will be evaluated by WOMAC. Data collectors and statisticians will be blinded, and participants will be asked not to reveal their allocation to assessors. DISCUSSION: The findings of this research will enhance the therapeutic approaches for early intervention in KOA, offer a scientific foundation for enabling patients with EKOA to engage in self-directed exercise, and contribute to the alleviation of social, medical, and economic burdens associated with the condition. TRIAL REGISTRATION: Chinese Clinical Trials Registry ChiCTR2400089758. Prospectively registered on 14 September 2024.
引用
- Wei C, Wang X, Xiong Y, et al. Efficacy of core muscle strengthening training around the knee compared to oral nonsteroidal anti-inflammatory drugs in early-stage knee osteoarthritis patients: protocol for a randomized controlled trial. Trials. 2025. PMID: 41327468. doi:10.1186/s13063-025-08996-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。